Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study Josefina Cortés-Hernández; Carlos Marras Fernández-Cid; Jose Luis Andreu Sánchez; Jaime Calvo Alén; Angel M. García-Aparicio; Elvira Díez Álvarez; Francisco Javier Hidalgo Bermejo; Carlos Coronell; Alessandra Perna; Josep Ordi Ros;

Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus Íñigo Rúa-Figueroa; Tarek Carlos Salman-Monte; José María Pego Reigosa; María Galindo Izquierdo; Elvira Díez Álvarez; Antonio Fernández-Nebro; José Andrés Román Ivorra; Inmaculada Calvo Penades; Joseba Artaraz Beobide; Jaime Calvo Alén;

Effectiveness and safety of rituximab in systemic lupus erythematosus: A case series describing the experience of 2 centres Vicenç Juan Gómez; Irene Carrión-Barberá; Tarek Carlos Salman Monte; Asunción Acosta; Vicenç Torrente-Segarra; Jordi Monfort;